Søren Østergaard

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Topics

Gas Chromatography Mass Spectrometry

Structure Activity Relationship

Top Venues

Journal of medicinal chemistry

Nature chemistry

Nature communications

Angewandte Chemie (International ed. in English)

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas Kruse, Søren Østergaard
Redefining peptide therapeutics with semaglutide. Nature chemistry 16 (2) (2024)
Thomas Kruse, Søren Østergaard
Redefining peptide therapeutics with semaglutide. Nature chemistry 16 (2) (2024)
Thomas Kruse, Søren Østergaard
Redefining peptide therapeutics with semaglutide. Nature chemistry (2024)
Javier R Balboa, Dominik J Essig, Sana Ma, Nichlas Karer, Louise S Clemmensen, Søren W Pedersen, Andreas C Joerger, Stefan Knapp, Søren Østergaard, Kristian Stro Mgaard
Development of a Potent Cyclic Peptide Inhibitor of the nNOS/PSD-95 Interaction. Journal of medicinal chemistry (2022)
Javier R Balboa, Dominik J Essig, Sana Ma, Nichlas Karer, Louise S Clemmensen, Søren W Pedersen, Andreas C Joerger, Stefan Knapp, Søren Østergaard, Kristian Stro Mgaard
Development of a Potent Cyclic Peptide Inhibitor of the nNOS/PSD-95 Interaction. Journal of medicinal chemistry 66 (1) (2022)
Peter Kurtzhals, Søren Østergaard, Erica Nishimura, Thomas B Kjeldsen
Derivatization with fatty acids in peptide and protein drug discovery. Nature reviews. Drug discovery (2022)
Gergő Gógl, Boglárka Zámbó, Camille Kostmann, Alexandra Cousido-Siah, Bastien Morlet, Fabien Durbesson, Luc Negroni, Pascal Eberling, Pau Jané, Yves Nominé, András Zeke, Søren Østergaard, Élodie Monsellier, Renaud Vincentelli, Gilles Travé
Author Correction: Quantitative fragmentomics allow affinity mapping of interactomes. Nature communications 13 (1) (2022)
Javier R Balboa, Dominik J Essig, Sana Ma, Nichlas Karer, Louise S Clemmensen, Søren W Pedersen, Andreas C Joerger, Stefan Knapp, Søren Østergaard, Kristian Stro Mgaard
Development of a Potent Cyclic Peptide Inhibitor of the nNOS/PSD-95 Interaction. Journal of medicinal chemistry 66 (1) (2022)
Javier R Balboa, Dominik J Essig, Sana Ma, Nichlas Karer, Louise S Clemmensen, Søren W Pedersen, Andreas C Joerger, Stefan Knapp, Søren Østergaard, Kristian Stro Mgaard
Development of a Potent Cyclic Peptide Inhibitor of the nNOS/PSD-95 Interaction. Journal of medicinal chemistry 66 (1) (2022)
Gergő Gógl, Boglárka Zámbó, Camille Kostmann, Alexandra Cousido-Siah, Bastien Morlet, Fabien Durbesson, Luc Negroni, Pascal Eberling, Pau Jané, Yves Nominé, András Zeke, Søren Østergaard, Élodie Monsellier, Renaud Vincentelli, Gilles Travé
Quantitative fragmentomics allow affinity mapping of interactomes. Nature communications 13 (1) (2022)
Søren Østergaard, Johan F Paulsson, Marina Kjaergaard Gerstenberg, Birgitte S Wulff
The Design of a GLP-1/PYY Dual Acting Agonist. Angewandte Chemie (International ed. in English) 60 (15) (2021)
Søren Østergaard, Johan F Paulsson, Jacob Kofoed, Franziska Zosel, Jørgen Olsen, Claus Bekker Jeppesen, Jane Spetzler, Lars Ynddal, Luise Gram Schleiss, Berit Østergaard Christoffersen, Kirsten Raun, Ulrich Sensfuss, Flemming Seier Nielsen, Rasmus Jørgensen, Birgitte S Wulff
The effect of fatty diacid acylation of human PYY3-36 on Y2 receptor potency and half-life in minipigs. Scientific reports 11 (1) (2021)
Heidi S Schultz, Søren Østergaard, John Sidney, Kasper Lamberth, Alessandro Sette
The effect of acylation with fatty acids and other modifications on HLA class II:peptide binding and T cell stimulation for three model peptides. PloS one 13 (5) (2018)
Søren Østergaard, Jacob Kofoed, Johan F Paulsson, Kim Grimstrup Madsen, Rasmus Jorgensen, Birgitte S Wulff
Design of Y2 Receptor Selective and Proteolytically Stable PYY3-36 Analogues. Journal of medicinal chemistry 61 (23) (2018)